U.S. markets closed
  • S&P 500

    3,465.39
    +11.90 (+0.34%)
     
  • Dow 30

    28,335.57
    -28.13 (-0.10%)
     
  • Nasdaq

    11,548.28
    +42.28 (+0.37%)
     
  • Russell 2000

    1,640.50
    +10.25 (+0.63%)
     
  • Crude Oil

    39.78
    -0.07 (-0.18%)
     
  • Gold

    1,903.40
    -1.80 (-0.09%)
     
  • Silver

    24.70
    +0.03 (+0.10%)
     
  • EUR/USD

    1.1858
    +0.0032 (+0.27%)
     
  • 10-Yr Bond

    0.8410
    -0.0070 (-0.83%)
     
  • GBP/USD

    1.3060
    -0.0020 (-0.16%)
     
  • USD/JPY

    104.6390
    -0.2010 (-0.19%)
     
  • BTC-USD

    13,039.67
    +22.14 (+0.17%)
     
  • CMC Crypto 200

    260.05
    -1.40 (-0.54%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,516.59
    +42.29 (+0.18%)
     

Benzinga Pro's Top 5 Stocks To Watch For Tues., Jan. 21, 2020: HAL, LB, NVAX, CAT, TCOM

Benzinga Newsdesk

Benzinga Pro's Stocks To Watch For Tuesday

  • Halliburton (HAL) - Reported better-than-expected Q4 earnings and sales. The stock was up 1% ahead of the open.

  • L Brands (LB) - Shares traded up more than 2% following a KeyBanc upgrade to Overweight. The firm set a $25 price target, which represented about 22% upside from where the stock was trading Tuesday morning.

  • Novavax (NVAX) - Following a 50+% rally last week amid news of FDA Fast Track Designation for its NanoFlu, the stock was up 62% in pre-market action Tuesday, likely related to the outbreak of coronavirus in China. Reports suggest more than 200 cases of the virus have been reported. The company's stock has in the past been sensitive to such outbreaks given its SARS-CoV treatment.

  • Caterpillar (CAT) - The stock traded lower despite an upgrade to Outperform by an analyst at Daiwa Capital.

  • Trip.com (TCOM) - In contrast to the price action that impacted Novavax and other vaccine manufacturers, China-based travel companies have seen stocks lower amid a concern travel into China will be impacted by the coronavirus outbreak.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.